Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Palmér

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2021
A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthmaJacob Leander, Mats Jirstrand, Ulf G Eriksson, et al.
The Journal of Biological Chemistry|April 28, 2010
Mass and information feedbacks through receptor endocytosis govern insulin signaling as revealed using a parameter-free modeling frameworkCecilia Brännmark, Robert Palmér, S Torkel Glad, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Respiratory Research|June 24, 2020
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trialsAgnieszka Król, Robert Palmér, Virginie Rondeau, et al.
Global Pediatric Health|April 15, 2021
Outcome of a Multi-modal CBT-based Treatment Program for Chronic School RefusalJohan Strömbeck, Robert Palmér, Ia Sundberg Lax, et al.
The Journal of Biological Chemistry|May 17, 2011
A hierarchical whole-body modeling approach elucidates the link between in Vitro insulin signaling and in Vivo glucose homeostasisElin Nyman, Cecilia Brännmark, Robert Palmér, et al.
Molecular Pharmaceutics|June 25, 2025
Physiologically Based Biopharmaceutic Lung Deposition Modeling to Guide Clinical Device Transition of Protein A from a Nebulizer to a Dry Powder InhalerFrans Franek, Tobias Bramer, Marja Savolainen, et al.
Molecular Systems Biology|April 26, 2012
A framework for mapping, visualisation and automatic model creation of signal-transduction networksCarl-Fredrik Tiger, Falko Krause, Gunnar Cedersund, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 25, 2021
Longitudinal FEV<sub>1</sub> and Exacerbation Risk in COPD: Quantifying the Association Using Joint ModellingKirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2021
A stochastic mixed effects model to assess treatment effects and fluctuations in home-measured peak expiratory flow and the association with exacerbation risk in asthmaJacob Leander, Mats Jirstrand, Ulf G Eriksson, et al.
The Journal of Biological Chemistry|April 28, 2010
Mass and information feedbacks through receptor endocytosis govern insulin signaling as revealed using a parameter-free modeling frameworkCecilia Brännmark, Robert Palmér, S Torkel Glad, et al.
Statistics in Medicine|March 13, 2026
Location-Scale Latent Process Model for Repeated Ordinal Patient-Reported OutcomesAgnieszka Król, Robert Palmér, Jacob Leander, et al.
Respiratory Research|June 24, 2020
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trialsAgnieszka Król, Robert Palmér, Virginie Rondeau, et al.
Global Pediatric Health|April 15, 2021
Outcome of a Multi-modal CBT-based Treatment Program for Chronic School RefusalJohan Strömbeck, Robert Palmér, Ia Sundberg Lax, et al.
The Journal of Biological Chemistry|May 17, 2011
A hierarchical whole-body modeling approach elucidates the link between in Vitro insulin signaling and in Vivo glucose homeostasisElin Nyman, Cecilia Brännmark, Robert Palmér, et al.
Molecular Pharmaceutics|June 25, 2025
Physiologically Based Biopharmaceutic Lung Deposition Modeling to Guide Clinical Device Transition of Protein A from a Nebulizer to a Dry Powder InhalerFrans Franek, Tobias Bramer, Marja Savolainen, et al.
Molecular Systems Biology|April 26, 2012
A framework for mapping, visualisation and automatic model creation of signal-transduction networksCarl-Fredrik Tiger, Falko Krause, Gunnar Cedersund, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 25, 2021
Longitudinal FEV<sub>1</sub> and Exacerbation Risk in COPD: Quantifying the Association Using Joint ModellingKirill Zhudenkov, Robert Palmér, Alexandra Jauhiainen, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Pageof 2